Top Story

Iluvien receives marketing authorization in Finland, Luxembourg

January 27, 2015

The Finnish Medicines Agency in Finland and the Ministry of Health in Luxembourg have granted Iluvien marketing authorization for the treatment of vision impairment associated with chronic diabetic macular edema, according to a press release from Alimera Sciences.

Iluvien (fluocinolone acetonide intravitreal implant) is approved for marketing in Austria, Belgium, Denmark, France, Germany, Ireland, Italy, the Netherlands, Norway, Portugal, Spain, Sweden, the United Kingdom and the United States. It is commercially available in the United Kingdom, Germany and Portugal, the release said.

SCORE2 to explore primary, secondary therapies for CRVO Meeting News Coverage

SCORE2 to explore primary, secondary therapies for CRVO

January 27, 2015
WAILEA, Hawaii — A new study is designed to examine first- and second-line treatments for central retinal vein occlusion, a speaker told colleagues…

Actavis, Allergan announce SEC declaration, shareholder meetings on pending acquisition

January 27, 2015
Actavis and Allergan announced that the U.S. Securities and Exchange Commission has declared Actavis’ registration statement on Form S-4 with regard to…
Speaker shares pearls for better glaucoma management Meeting News Coverage

Speaker shares pearls for better glaucoma management

January 27, 2015
WAILEA, Hawaii — A speaker presented his pearls for better glaucoma management here at Hawaiian Eye 2015.Physicians should avoid unforced errors in glaucoma, Thomas W
thumbnail for video 4012733766001 Meeting News CoverageVideo

VIDEO: SightLife CEO updates global cornea transplantation achievements, goals

January 27, 2015
WAILEA, Hawaii – At Hawaiian Eye 2015, Monty Montoya, president and CEO of SightLife, discusses the organizations achievements and future goals for making corneal…
More News Headlines »
Case Report

Regression of Macular Drusenoid Retinal Pigment Epithelial Detachments After Plaque Radiation Therapy

Ophthalmic Surgery, Lasers and Imaging Retina, January/February 2015, Volume 46 Issue 1
The authors describe a case in which drusenoid retinal pigment epithelial detachments (DRPEDs) melted after plaque…
More »
CME
Haller

Diabetic Eye Disease: Implications of Early Recognition, Treatment, and Continuity of Care

This activity is supported by an educational grant from Genentech, Inc.

Diabetic retinopathy is a leading cause of new cases of legal blindness among working-age Americans. Initially…
More »
Meeting News Coverage Video
thumbnail for video 4007655235001

VIDEO: Surgeon updates Jetrea clinical safety

January 26, 2015
WAILEA, Hawaii – At Hawaiian Eye 2015, Peter Kaiser, MD, discusses the safety coniderations for patients undergoing…
More »